Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC7 | O00311 | 4/20 | 0.71 |
| ▸ | ROCK2 | O75116 | 4/20 | 0.71 |
| ▸ | MAP4K4 | O95819 | 4/20 | 0.71 |
| ▸ | CDK2 | P24941 | 4/20 | 0.71 |
| ▸ | GSK3B | P49841 | 4/20 | 0.71 |
| ▸ | CLK4 | Q9HAZ1 | 4/20 | 0.71 |
| ▸ | IRAK4 | Q9NWZ3 | 4/20 | 0.71 |
| ▸ | MKNK2 | Q9HBH9 | 2/20 | 0.71 |
| ▸ | PRKACA | P17612 | 3/20 | 0.70 |
| ▸ | HIPK2 | Q9H2X6 | 2/20 | 0.61 |
| ▸ | CHEK1 | O14757 | 14/20 | 0.60 |
| ▸ | KDR | P35968 | 1/20 | 0.55 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.47 |
| ▸ | FER | P16591 | 1/20 | 0.47 |
| ▸ | LTK | P29376 | 1/20 | 0.47 |
| ▸ | CDK8 | P49336 | 1/20 | 0.47 |
| ▸ | ACVR1 | Q04771 | 1/20 | 0.47 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.47 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4852322 | 0.83 | MAP4K4 (0.51) | CDC7ROCK2MAP4K4CDK2GSK3B | |
| SCHEMBL4858583 | 0.80 | CHEK1 (0.49) | CDC7ROCK2MAP4K4CDK2GSK3B | |
| SCHEMBL4852451 | 0.80 | ROCK2 (0.70) | CDC7ROCK2MAP4K4CDK2GSK3B | |
| SCHEMBL4859172 | 0.79 | CHEK1 (0.50) | CDC7ROCK2MAP4K4CDK2GSK3B | |
| SCHEMBL4850248 | 0.77 | CHEK1 (0.64) | CDC7ROCK2MAP4K4CDK2GSK3B | |
| SCHEMBL16712562 | 0.74 | ACVR1 (0.62) | CDC7ROCK2MAP4K4CDK2GSK3B | |
| SCHEMBL4851403 | 0.73 | ABL1 (0.54) | ROCK2CDK2GSK3BIRAK4CHEK1 | |
| SCHEMBL4854179 | 0.69 | CHEK1 (1.00) | CDC7ROCK2MAP4K4CDK2GSK3B | |
| SCHEMBL22068158 | 0.69 | IDO1 (0.55) | MAP4K4 | |
| SCHEMBL4858358 | 0.69 | CHEK1 (0.74) | CDC7ROCK2MAP4K4CDK2GSK3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1606268-B1 | 5,10-DIHYDRO-11H-DIBENZO[B,E][1,4]DIAZEPIN-11-ONE AS KINASE INHIBITORS | ABBVIE INC (US) | 2015-05-20 | — | — | EP | disclosed |
| US-7456169-B2 | Heterocyclic kinase inhibitors | ABBOTT LABORATORIES INC. (US) | 2008-11-25 | — | — | US | disclosed |
| US-20070254867-A1 | Heterocyclic Kinase Inhibitors | ABBVIE INC. | 2007-11-01 | — | — | US | disclosed |
| US-20040254159-A1 | Heterocyclic kinase inhibitors | ABBOTT LABORATORIES | 2004-12-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040254159-A1 | Heterocyclic kinase inhibitors | MAP3K20, MAP3K19, MAP3K1 | CDC7 49/4885ROCK2 486/4885MAP4K4 26/4885 |
| US-20070254867-A1 | Heterocyclic Kinase Inhibitors | MAP3K20, MAP3K19, MAP4K2 | CDC7 50/4885ROCK2 483/4885MAP4K4 35/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.